secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0000950170-24-022110
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare reports Q4 rev $65.9M (+9% YoY); FY23 net loss $289.6M; guides FY24 rev $263-269M
--------------------------------------------------------------------------------

- Q4 revenue $65.9M (+9% YoY); FY23 revenue $251.4M (+13% YoY).
- Q4 net loss $13.4M (20% of rev) vs net income $5.9M in Q4 2022; FY23 net loss $289.6M.
- Adjusted EBITDA Q4 $19.8M (30% margin); FY23 $74.5M (30% margin).
- Guidance: Q1 2024 rev $63–65M (6–10% YoY); FY2024 rev $263–269M (5–7% YoY).
- Added 28 enterprise clients in Q4; total enterprise customers at 565 with >$100K ARR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024022110/0000950170-24-022110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024022110/dh-20240228.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-022110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer